0001628280-24-026221.txt : 20240603
0001628280-24-026221.hdr.sgml : 20240603
20240603121850
ACCESSION NUMBER: 0001628280-24-026221
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240530
FILED AS OF DATE: 20240603
DATE AS OF CHANGE: 20240603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sigal Charles Elliott
CENTRAL INDEX KEY: 0001661908
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 241012747
MAIL ADDRESS:
STREET 1: 32 BREARLY ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
wk-form4_1717431521.xml
FORM 4
X0508
4
2024-05-30
0
0001706431
Vir Biotechnology, Inc.
VIR
0001661908
Sigal Charles Elliott
C/O VIR BIOTECHNOLOGY, INC.
1800 OWENS STREET, SUITE 900
SAN FRANCISCO
CA
94158
1
0
0
0
0
Common Stock
2024-05-30
4
A
0
8000
0
A
23806
D
Common Stock
10000
I
By Sigal Family Investments, LLC
Stock Option (Right to Buy)
10.39
2024-05-30
4
A
0
16000
0
A
2025-05-30
2034-05-29
Common Stock
16000
16000
D
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
/s/ Vanina de Verneuil, Attorney-In-Fact
2024-06-03